Founding Team
Nicole Baker, PhD
CEO
Immunologist and Pharmacovigilance Professional with strong focus on innovation and extensive knowledge in global legislation and guidelines for Medical Affairs, Regulatory Affairs, Pharmacovigilance and Clinical Trials, gained by leading and managing global, multi-disciplinary teams.
Extensive experience in providing strategic, operational and scientific leadership throughout the product life-cycle, from pre-clinical to post-marketing.
Overall 20 years’ experience gained within Academia, Pharmaceutical Industry, Regulatory Authority, Clinical Research Organisation, and more recently Start-up.
Bruno Ohana, PhD
CTO
Experienced Technologist and Engineering Leader with broad industry experience spanning a career of over 20 years, having performed senior engineering/engineering management roles on large scale Cloud Infrastructure, Fintech, Healthcare and Artificial Intelligence Services.
Academic and Industry Partners
Get in Touch
Contact us to learn more about how we use artificial intelligence to deliver faster, accurate and high quality literature screening for drug safety.